HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enantioselectivity in the steady-state pharmacokinetics and transplacental distribution of pindolol at delivery in pregnancy-induced hypertension.

Abstract
Nine patients taking oral doses of 10 mg/12 h rac-pindolol as part of their treatment for hypertension in pregnancy were recruited for the study. Maternal and fetal gestational age ranged from 20-38 years and 28-41 weeks, respectively. Blood was collected from the umbilical cord vein and from the mother from zero to 12 h after drug administration. Urine was collected for 12 h after rac-pindolol administration at the following intervals: 0-3, 3-6, 6-9, and 9-12 h. Plasma and urine concentrations of the pindolol enantiomers were determined by HPLC using a Chiralpak AD chiral column and fluorescence detection. The data were fitted to a one-compartment model and differences between (+)-R and (-)-S enantiomers were compared by the paired t-test (P < 0.05). Mean results are reported. The disposition of pindolol in maternal plasma was stereoselective, with higher AUC(SS)0-12 (84.34 vs. 95.69 ng.h/ml) and Cl(R) values (9.16 vs. 10.85 L/h) and lower Vd/f (251.38 vs. 225.17 L) and Cl/f (62.48 vs. 55.74 L/h) for the (+)-R pindolol. The transplacental distribution of pindolol was not stereoselective. Cord, plasma, and presumably fetal, concentrations of the pindolol enantiomers were 56% of the maternal plasma concentrations up to 6 h after the last dose.
AuthorsPaulo Vinicius Bernardes Gonçalves, Angelo Do Carmo Silva Matthes, Sérgio Pereira Da Cunha, Vera Lucia Lanchote
JournalChirality (Chirality) Vol. 14 Issue 8 Pg. 683-7 (Aug 2002) ISSN: 0899-0042 [Print] United States
PMID12125040 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2002 Wiley-Liss, Inc.
Chemical References
  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Pindolol
Topics
  • Adrenergic beta-Antagonists (pharmacokinetics)
  • Adult
  • Antihypertensive Agents (pharmacokinetics)
  • Female
  • Humans
  • Hypertension (drug therapy, metabolism)
  • Pindolol (pharmacokinetics)
  • Placenta (metabolism)
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (drug therapy, metabolism)
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: